About NexGen Pharmaceuticals
NexGen Pharmaceuticals is a company based in Weatherford (United States) founded in 2017 was acquired by Mixlab in May 2024. NexGen Pharmaceuticals offers products and services including Furosemide Oral Solution, Neo-Poly-Bac, and Baytril 100. NexGen Pharmaceuticals operates in a competitive market with competitors including Mixlab, Vetcove, PetCareRx, Furmacy and FluffyRx, among others.
- Headquarter Weatherford, United States
-
Sectors
ConsumerHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NexGen Pharmaceuticals
NexGen Pharmaceuticals offers a comprehensive portfolio of products and services, including Furosemide Oral Solution, Neo-Poly-Bac, and Baytril 100.
Effective diuretic medication for treating fluid retention in pets.
Treats bacterial eye infections in animals like dogs and cats.
Antimicrobial solution for bovine health and infection treatment.
Funding Insights of NexGen Pharmaceuticals
Detailed funding history for NexGen Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in NexGen Pharmaceuticals
NexGen Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Mixlab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Customized veterinary medications are compounded and delivered by Mixlab.
|
Locked | Locked | Locked |
Investor details for NexGen Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NexGen Pharmaceuticals
Investment portfolio details for NexGen Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NexGen Pharmaceuticals
Detailed financials for NexGen Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nexgen Pharmaceuticals Comparisons
Peer comparison for NexGen Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NexGen Pharmaceuticals
NexGen Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mixlab, Vetcove, PetCareRx, Furmacy and FluffyRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Customized veterinary medications are compounded and delivered by Mixlab.
|
|
| Locked | Locked | Locked |
An online B2B marketplace is operated for veterinary supply sourcing.
|
|
| Locked | Locked | Locked |
Pet supplies and medications are retailed online by PetCareRx.
|
|
| Locked | Locked | Locked |
Platform offering healthcare services and products for pets
|
|
| Locked | Locked | Locked |
Provides pet medication discounts via app, searches for lowest prices, and partners with pharmacies.
|
Detailed competitors of NexGen Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nexgen Pharmaceuticals
Complete news archive for NexGen Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NexGen Pharmaceuticals
NexGen Pharmaceuticals was founded in 2017.
NexGen Pharmaceuticals is headquartered in Weatherford, United States. It is registered at Weatherford, Texas, United States.
Michael Russin is the current CEO of NexGen Pharmaceuticals.
NexGen Pharmaceuticals was established in 2017 in Weatherford, United States, as an online pharmacy focused on veterinary pharmaceuticals. Products for equines, companion animals, and wildlife are distributed, encompassing formulations for breeding, sedation, antibiotics, antifungals, and additional categories. Operations center on e-commerce delivery of these specialized medications to support animal health needs across the sector.
NexGen Pharmaceuticals offers Furosemide Oral Solution, Neo-Poly-Bac, and Baytril 100.
NexGen Pharmaceuticals has 1 investor. Key investors include Mixlab.